CSIRO’s deal on development of non-contact sensor technology
CSIRO has announced the signing of a licensing agreement with Melbourne based bio-technology medical device company, HD Medical Group Limited, for commercial application of its non-contact sensor technology.
The exclusive global agreement will support development of devices that detect, analyse and diagnose structural cardiac faults.
CSIRO and HD Medical envisage a worldwide market for these products which are unique in their applicability to both developed and developing countries.
HD Medical, says that the company has already been awarded a competitive Commercialising Emerging Technologies grant by the Federal Government for its patented and patent-pending breakthrough technology that helps in early detection of cardio-vascular defects.
CSIRO’s Vital Signs Sensor Technology (patent pending) is the result of research completed by the Wireless Technologies Laboratory in the CSIRO ICT Centre in Sydney, and uses a unique Radio Frequency method to monitor heart and lung conditions without skin contact and over clothing.
Clinical trials and product development are expected to proceed immediately, with HD Medical targeting the supply of the technology to the global market over the next two years.
